Amneal ‘Hyper Focused’ On New Launches

As Generics Business Exceeds Expectations In The First Quarter

Amneal reports double-digit growth across all segments • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business